Novolin 70/30

Product manufactured by Novo Nordisk

Application Nr Approved Date Route Status External Links
BLA019991 None Subcutaneous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Novolin 70/30 Is Indicated To Improve Glycemic Control In Adults And Pediatric Patients With Diabetes Mellitus. Limitations Of Use: In Novolin 70/30, The Proportions Of Short-Acting And Intermediate-Acting Insulins Are Fixed And Do Not Allow For Basal Versus Prandial Dose Adjustments. Novolin 70/30 Is A Mixture Of Human Insulin Isophane, An Intermediate-Acting Human Insulin, And Human Insulin, A Short-Acting Human Insulin, Indicated To Improve Glycemic Control In Adults And Pediatric Patients With Diabetes Mellitus. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Insulin Human

Comments